Stryker Corporation (SYK) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Total Assets Chart for Stryker Corporation
Stryker Corporation (SYK) total assets for FY2025 were USD 47.8B, a 11.3% change from FY2024. Stryker Corporation's total assets grew from USD 70.7M in 1985 to USD 47.8B in 2025 (67571.9% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 6.9%, 10-year CAGR of 11.4%, 20-year CAGR of 12.0%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $129.43B
- Implied Share Price
- $337.43
- Enterprise Value
- $140.74B
- Revenue (TTM)
- $25.84B
- EBITDA
- $7.38B
- Profit Margin
- 14.43%
- Trailing P/E
- 34.97
- Forward P/E
- 22.37
- Price/Book (MRQ)
- 5.37
- Price/Sales (TTM)
- 5.01
- EV/EBITDA
- 20.14
- EV/Revenue
- 5.43
- Dividend Yield
- 1.03%
- Book Value
- $59.94
- Free Cash Flow (FY2025)
- $4.28B
- Free Cash Flow Yield
- 3.31%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.